• Moderna-Coronavirus-vacine-770x433.jpg

    Eight Covid-19 vaccines being worked on and could be available by ‘late fall’

    13 May, 2020
    At least eight candidates for a coronavirus vaccine are in the clinical development stage, and some could be ready as early as the “late fall”, Anthony Fauci, the US’ top infectious disease expert, has told senators.
    “The [National Institutes of Health] has been collaborating with a number of pharmaceutical companies at various stages of development,” Mr Fauci said, in testimony on Tuesday.

    As part of that plan, the administration is moving ahead with production of the...
  • 1800x-1.jpg

    Spain Reports Fewest Deaths Since March as Lockdown Set to Ease

    12 May, 2020

    Spain recorded fewer fatalities from the coronavirus as about half the country’s population awaits a further easing of lockdown restrictions starting Monday.

    The number of deaths in the last 24 hours was 143, the lowest tally since March 18, versus 179 the previous day, according to Health Ministry data. The number of new cases rose by 621, slightly more than 604 the previous day.

    The government has authorized a further partial easing of restrictions from Monday fo...
  • baixa.jpeg

    Triple drug therapy helps coronavirus patients recover more quickly

    11 May, 2020

    A combination of three antiviral drugs plus an immune system booster seemed to help patients recover more quickly from coronavirus infections, doctors in Hong Kong reported Friday.

    They said the approach needs more testing but it could offer another treatment possibility for Covid-19 patients. Currently the only authorized treatment is the experimental antiviral drug remdesivir, which also shortens the duration of illness but is limited in supply.
    Dr. Kwok-Yung...
  • descarga_15_.jpeg

    After Recovery From the Coronavirus, Most People Carry Antibodies

    8 May, 2020
    A new study adds to evidence of immunity among those who have already been exposed to the pathogen.
    A new study offers a glimmer of hope in the grim fight against the coronavirus: Nearly everyone who has had the disease — regardless of age, sex or severity of illness — makes antibodies to the virus.

    The study, posted online on Tuesday but not yet reviewed by experts, also hints that anyone who has recovered from infection may safely return to work — although it is unclear how long t...
  • grifols.jpeg

    Grifols completes development of very high sensitivity molecular test to detect SARS-CoV-2 virus

    6 May, 2020
    The company has developed the test in record time in a global coordinated effort of its facilities in San Diego, Barcelona and Bilbao, and has recently received the authorization of the Spanish Medicines and Medical Devices Agency (AEMPS) for its use in blood, plasma and respiratory samples. It has a sensitivity equal or even superior to that of other molecular tests currently available, such as those based on PCR.

    Thanks to this high sensitivity, the molecular test will also ...
  • 200427144340-contact-tracing-exlarge-169.jpg

    UK starts testing coronavirus contact tracing app

    5 May, 2020

    The UK government launched its first test of a coronavirus contact tracing app Monday on a small island off the south coast of England.

    Using bluetooth technology, the app will alert users if they have been near someone who has tested positive for the virus. The app, which was developed by the digital technology unit of the National Health Service (NHS), will also upload information to a central database to help public health experts study the behavior of the virus.
    Click here f...
  • Apr13_2020_Getty_1216735230_COVID19Medicine-436x300.jpg

    Two drugs show promise against COVID-19

    5 May, 2020

    Both drugs are FDA-approved for other illnesses.

    Korean researchers have screened 48 FDA-approved drugs against SARS-CoV-2, and found that two, that are already FDA-approved for other illnesses, seem promising. The FDA approval for other uses would greatly reduce the time needed to gain FDA approval of use in COVID-19. The research is published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.

  • NZ.jpg

    New Zealand records first day with no new Covid-19 cases since before lockdown

    4 May, 2020

    New Zealand has recorded its first day of no new cases of Covid-19 since a stringent national lockdown began more than one month ago.

    The public has been engrossed by the daily release of case numbers by the health ministry each afternoon – especially as a deadline looms for the prime minister, Jacinda Ardern, to decide whether the country’s lockdown rules will ease further next Monday.

    One week into level-3 restrictions, however, officials sounded a cautious note as br...
  • remdesivir-previene-covid-redes.jpg

    Hopes rise on coronavirus drug remdesivir

    30 Apr, 2020
    Despite conflicting data, results from largest trial that show the antiviral speeds up recovery will make the treatment a standard of care in the United States.An experimental drug — and one of the world’s best hopes against COVID-19 — could shorten the time to recovery from coronavirus infection, according to the largest and most rigorous clinical trial of the compound.

    The experimental drug, called remdesivir, interferes with replication of some viruses, including...
  • Captura_de_pantalla_2020-04-28_a_las_10_12_05.png

    COVID-19 vaccine protects monkeys from new coronavirus, Chinese biotech reports

    28 Apr, 2020

    For the first time, one of the many COVID-19 vaccines in development has protected an animal, rhesus macaques, from infection by the new coronavirus, scientists report. The vaccine, an old-fashioned formulation consisting of a chemically inactivated version of the virus, produced no obvious side effects in the monkeys, and its human trial is about to begin.

    Researchers from Sinovac Biotech, a privately held Beijing-based company, gave two different doses of their COV...
  • jnj.jpg

    Johnson & Johnson Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine

    27 Apr, 2020
    Company Signs Agreement with Emergent BioSolutions in the U.S. As Part of its InvestmentFirst in Series of Anticipated Strategic Collaborations Designed to Further the Company’s Goal of Ensuring Global Supply of a Safe and Effective Vaccine for COVID-19
    Johnson & Johnson (the Company) (NYSE: JNJ) on 23rd April 2020 announced a collaboration between the Janssen Pharmaceutical Companies of Johnson & Johnson and Emergent BioSolutions, Inc. to support the manufacturing of its lead inve...
  • 2_Doctor-preparing-the-coronavirus-COVID-19-vaccine.jpg

    Germany to begin first clinical trial of COVID-19 vaccine candidate

    24 Apr, 2020
    A Phase I/II clinical trial for BioNTech’s BNT162 vaccine programme to prevent COVID-19 infection has been granted approval in Germany.BioNTech SE, have announced today that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase I/II clinical trial for the company’s BNT162 vaccine programme to prevent COVID-19 infection. 

    BioNTech and Pfizer...